Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

Profit-booking drags Nifty below 25,200; Pharma holds firm as metals, durables bleed

Market breadth turned decisively negative. On BSE, 1,400 stocks declined against 1,236 advances, with 184 unchanged.

Profit-booking drags Nifty below 25,200; Pharma holds firm as metals, durables bleed

India's benchmark indices witnessed a sharp decline in mid-session trading on Wednesday, with the Nifty 50 dropping below the critical 25,200 support level. The decline was driven by accelerated profit-taking and a weakening dollar, which in turn affected gold, silver, platinum, and palladium prices. Pharma emerged as the sole major sectoral outperformer, led by Cipla and Sun Pharma.

Consumer staples such as Tata Consumer Products and Kotak Bank also showed resilience. However, bank stocks led the sell-off, with SBI, Kotak Bank, and ICICI Bank contributing to the decline. Consumer durables and metals, including Titan, HDFC Life, Adani Enterprises, Hindalco, and BSE, bore the brunt of the sell-off. The rupee strengthened for the third consecutive day due to a weaker dollar, lower oil prices, and hawkish signals from the Federal Reserve.

The Sensex has immediate support at 81,700, while the Nifty's critical support band is now at the 25,090–25,110 zone.

Written by urgent.news from Hindu BusinessLine's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

Read the original at thehindubusinessline.com →

More in Finance & Markets

More from Wednesday 18 November →